Calendar of gene regulation events online

 

The calendar below lists webinars and virtual meetings relevant to gene regulation. All times below are in BST (British Summer Time). The link to export these events to Outlook or Google Calendar is at the bottom of this page. The calendar below includes all virtual events related to gene regulation, not limited to those organised by Fragile Nucleosome. To add your own virtual event that is not yet in our list, fill in this form. For a list of traditional (non-virtual) conferences in the area of gene regulation, see the separate page “conferences, meetings and schools”. Also, have a look at complementary lists of webinars at  The Node (developmental biology and related subjects), Physics of Life (biophysics) and mathseminars.org (mathematics & physics).

 

Loading Events

« All Events

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

October 27 @ 5:00 pm UTC+0

Free

Title: The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Date: Tuesday, October 27, 2020

Time: 11:00 AM Eastern Daylight Time

Duration: 1 hour

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.

The use of circulating tumor DNA (ctDNA) as a surrogate sample type for tumor tissue is an area of significant clinical interest. ctDNA has been demonstrated to mirror the solid tumor mutational landscape and has the potential for early diagnosis of cancer as well as monitoring and tracking biomarkers associated with residual disease over time.

Despite this promise, there are still open questions regarding the best way to implement liquid biopsy approaches in the clinical setting. Our panel brings together academic, clinical, and industry experts in liquid biopsy technologies who will describe the applications of this technique and discuss its benefits and shortcomings in the context of cancer care.

Ed Schuuring, PhD
Ed Schuuring, PhD
Professor of Molecular Oncological Pathology
University of Groningen

Sandi Deans, PhD
Sandi Deans, PhD
Consultant Clinical Scientist and Director
Genomics Quality Assessment

Claudia Vollbrecht, PhD
Claudia Vollbrecht, PhD
Scientific Associate
Institute of Pathology, Charité – Universitätsmedizin Berlin